Historical record - last NADAC effective date: 3/27/2015
Product Information
MYSOLINE 50 MG TABLET is a brand product labeled by Bausch Health US LLC, priced at $11.5447 per EA under NDC 66490069010. Its NADAC has been published 125 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Primidone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Bausch Health US LLCNDC
66490069010
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
3/27/2015
Active Ingredients
PRIMIDONEApproval Type
New Drug (NDA)
FDA Application
NDA009170FDA Approved
Before 1982
TE Code
AB
On Market Since
6/24/2009
Pharmacological Classes
Price Statistics
The NADAC for MYSOLINE 50 MG TABLET has been published 125 times since Nov 28, 2013, and over the history we have for it it has risen 335.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.5447 per EA |
|---|---|
| All-time high | $11.5447 (Apr 13, 2016) |
| All-time low | $2.6518 (Nov 28, 2013) |
| Median price | $9.5585 |
| Average price | $8.3026 |
| Largest weekly change | +50.0% (Jul 23, 2014) |
| Weeks tracked | 125 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+335.4%
Last surveyed Apr 13, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch Health US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Primidone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MYSOLINE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MYSOLINE 50 MG TABLET, manufactured by Bausch Health US LLC, is $11.5447 per EA (NDC 66490069010), effective Apr 13, 2016.
How has the price of MYSOLINE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for MYSOLINE 50 MG TABLET has risen 335.4%. It has been tracked across 125 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MYSOLINE 50 MG TABLET?
Since Nov 28, 2013, the NADAC for MYSOLINE 50 MG TABLET has ranged from a low of $2.6518 (Nov 28, 2013) to a high of $11.5447 (Apr 13, 2016), with a median of $9.5585 per EA.
Are there cheaper alternatives to MYSOLINE 50 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PRIMIDONE 50 MG TABLET, is $0.0914 per EA — about 99% below MYSOLINE 50 MG TABLET.
Who manufactures MYSOLINE 50 MG TABLET?
MYSOLINE 50 MG TABLET (NDC 66490069010) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.